These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24142067)

  • 1. Hyperglycemia, acute insulin resistance, and renal dysfunction in the early phase of ST-elevation myocardial infarction without previously known diabetes: impact on long-term prognosis.
    Lazzeri C; Valente S; Chiostri M; Attanà P; Mattesini A; Nesti M; Gensini GF
    Heart Vessels; 2014 Nov; 29(6):769-75. PubMed ID: 24142067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.
    Wang CH; Zhang SY; Fang Q; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ
    Am J Med Sci; 2015 May; 349(5):413-20. PubMed ID: 25782335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.
    Jia S; Zhao Y; Yang J; Zhao X; Xu H; Gao R; Wang Q; Li J; Yuan J; Yang Y
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):793-799. PubMed ID: 30637931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related differences in glucose abnormalities in women with ST-elevation myocardial infarction submitted to percutaneous coronary intervention: a single-center experience.
    Lazzeri C; Gensini GF; D'Alfonso MG; Chiostri M; Attanà P; Valente S
    J Cardiovasc Med (Hagerstown); 2015 May; 16(5):321-5. PubMed ID: 24911194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes.
    Vavalle JP; van Diepen S; Clare RM; Hochman JS; Weaver WD; Mehta RH; Pieper KS; Patel MR; Patel UD; Armstrong PW; Granger CB; Lopes RD
    Am Heart J; 2016 Mar; 173():57-66. PubMed ID: 26920597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The glucose dysmetabolism in the acute phase of non-diabetic ST-elevation myocardial infarction: from insulin resistance to hyperglycemia.
    Lazzeri C; Valente S; Chiostri M; Attanà P; Picariello C; Gensini GF
    Acta Diabetol; 2013 Jun; 50(3):293-300. PubMed ID: 21984048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Kume K; Yasuoka Y; Adachi H; Noda Y; Hattori S; Araki R; Kohama Y; Imanaka T; Matsutera R; Kosugi M; Sasaki T
    Cardiovasc Revasc Med; 2013; 14(5):253-7. PubMed ID: 23993293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Saji K; Namiuchi S; Sugie T; Takii T; Kato A
    Cardiovasc Interv Ther; 2017 Oct; 32(4):318-324. PubMed ID: 27435738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
    Planer D; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Xu K; Fahy M; Mehran R; Stone GW
    Int J Cardiol; 2013 Sep; 167(6):2572-9. PubMed ID: 22795245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria in non-diabetic STEMI: an independent predictor for acute kidney injury.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Attanà P; Gensini GF
    Scand Cardiovasc J; 2012 Dec; 46(6):324-9. PubMed ID: 22694718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of estimated glomerular filtration rate on periprocedural myocardial infarction in patients undergoing elective percutaneous coronary intervention.
    Vatankulu MA; Murat SN; Demircelik B; Turfan M; Sonmez O; Duran M; Bacaksiz A; Ornek E; Tasal A; Goktekin O
    Ren Fail; 2013 Aug; 35(7):931-5. PubMed ID: 23803143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated admission serum creatinine predicts poor myocardial blood flow and one-year mortality in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Zhao L; Wang L; Zhang Y
    J Invasive Cardiol; 2009 Oct; 21(10):493-8. PubMed ID: 19805833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital peak glycemia and prognosis in STEMI patients without earlier known diabetes.
    Lazzeri C; Valente S; Chiostri M; Picariello C; Gensini GF
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):419-23. PubMed ID: 20517158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Wang Z; Ren L; Lei L; Ye H; Peng J
    Acta Cardiol; 2016 Apr; 71(2):241-6. PubMed ID: 27090048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction].
    Karetnikova VN; Kalaeva VV; Evseeva MV; Osokina AV; Kashtalap VV; Gruzdeva OV; Shafranskaya KS; Zykov MV; Barbarash OL
    Ter Arkh; 2016; 88(6):26-32. PubMed ID: 27296258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal insufficiency is an independent predictor of in-hospital mortality for patients with acute myocardial infarction receiving primary percutaneous coronary intervention.
    Li JP; Momin M; Huo Y; Wang CY; Zhang Y; Gong YJ; Liu ZP; Wang XG; Zheng B
    J Zhejiang Univ Sci B; 2012 Aug; 13(8):638-44. PubMed ID: 22843184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention.
    Pres D; Gasior M; Strojek K; Gierlotka M; Hawranek M; Lekston A; Wilczek K; Tajstra M; Gumprecht J; Poloński L
    Kardiol Pol; 2010 Jul; 68(7):743-51. PubMed ID: 20648428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention.
    Lazzeri C; Sori A; Chiostri M; Gensini GF; Valente S
    Eur J Anaesthesiol; 2009 Oct; 26(10):856-62. PubMed ID: 19367169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal insufficiency was correlated with 2-year mortality for rural female patients with ST-segment elevation acute myocardial infarction after reperfusion therapy: a multicenter, prospective study.
    Gao Y; Jiang D; Zhang B; Sun Y; Ren L; Fan D; Qi G
    BMC Cardiovasc Disord; 2015 Dec; 15():179. PubMed ID: 26702638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.